Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components

Journal of Medical Microbiology

Volumn 48, Issue 2, 1999, Pages 195-203

  Fernandes, Karla S S ^a   Mathews, Herbert L ^b   Bezerra, Leila M Lopes ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE; RHAMNOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL WALL; COLONY FORMING UNIT; FUNGUS CULTURE; GRANULOMATOSIS; LIVER; LUNG; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPOROTHRIX SCHENCKII; VIRULENCE;

SPOROTHRIX SCHENCKII;

EID: 0032803902     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-2-195     Document Type: Article

References (22)

1. Travassos LR. 'Sporothrix schenckii'. In: Szaniszlo PJ (ed) Fungal dimorphism, with emphasis on fungi pathogenic for humans. New York, Plenum Press. 1985: 121-163.
2. Castrejón OV, Rubles M, Zubieta Arroyo OE. Fatal fungaemia due to Sporothrix schenckii. Mycoses 1995; 38: 373-376.
3. Farley ML, Fagan MF, Mabry LC, Wallace RJ. Presentation of Sporothrix schenckii in pulmonary cytology specimens. Acta Cytol 1991; 35: 389-395.
4. Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 1991; 5: 1243-1246.
5. Padhye AA, Kaufman T., Durry E et al. Fatal pulmonary sporotrichosis caused by Sporothrix schenckii var. luriei in India. J Clin Microbiol 1992; 30: 2492-2494.
6. Charoenvit Y, Taylor RL. Experimental sporotrichosis in Syrian hamsters. Infect Immun 1979; 23; 366-372.
7. Dixon DM, Duncan RA, Hurd NJ. Use of mouse model to evaluate clinical and environmental isolates of Sporothrix sp. from the largest U.S. epidemic of sporotrichosis. J Clin Microbiol 1992; 30: 951-954.
8. Dickerson CL, Taylor RL, Drutz DJ. Susceptibility of congenially athymic (nude) mice 10 sporotrichosis. Infect Immun 1983, 40: 417-420.
9. Restrepo-Gutierrez S, Arango-Arteaga M, Uribe-Jaramillo F, Zuluaga-Cadena AI, Restrepo-Moreno A. Course of experimental murine infection induced by Sporothrix schenckii conidia according to depth of inoculation. J Med Vet Mycol 1993; 31: 411-420.
10. Miyaji M, Nishimura K. Defensive role of granuloma against Sporothrix schenckii infection. Mycopathalogia 1982; 80: 117-124.
11. Garrison RG, Boyd KS, Mariat F. Ultrastructural studies of the mycelium-to-yeast transformation of Sporothrix schenckii. J Bacteriol 1975; 124: 959-968.
12. Travassos I.R. Antigenic structures of Sporothrix schenckii. In: Kurstak E (ed) Immunology of fungal diseases. New York, Marcel Dekker. 1989: 193-221.
13. Takata M, Ishizaki H. Correlation among culture times, sugar composition and biological activities of Sporothrix schenckii antigens. Mycophatologia 1983, 84: 31-39.
14. Lopes Alves L, Travassos LR, Previato JO, Mendonça-Previato L. Novel antigenic determinants from peptidorhamnomannans of Sporothrix schenckii. Glycobiology 1994; 4: 281-288.
15. Lopes Alves LM, Mendonça-Previato L, Fournet B, Degand P, Previato JO. O-glycosiclically linked oligosaccharides from peptidorhamnomannans of Sporothrix schenckii. Glycoconjugate J 1992; 9: 75-81.
16. Lloyd KO. Isolation, characterization, and partial structure of peptidogalactomannans from the yeast form of Cladosporium werneckii. Biochemistry 1970; 9: 3446-3453.
17. Mencacci A, Torosantucci A, Spaccapelo R, Romani L, Bistoni F, Cassone A. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect Immun 1994; 62: 5353-5360.
18. Kozel TR. Virulence factors of Cryptococcus neoformans. Trends Microbiol 1995; 3: 295-299.
19. Irokanulo EAO, Akueshi CO. Virulence of Cryptococcus neoformans serotypes A, B, C and D for four mouse strains. J Med Microbiol 1995; 43: 289-293.
20. Lloyd KO, Travassos LR. Immunochemical studies on L-rhamno-D-mannans of Sporothrix schenckii and related fungi by use of rabbit and human antisera. Carbohydr Res 1975; 40: 89-97.
21. Lloyd KO, Bitoon MA. Isolation and purification of a peptido-rhamnomannan from the yeast form of Sporothrix schenckii. Structural and immunochemical studies. J Immunol 1971; 107: 663-671.
22. Travassos LR, Mendonça-Previato L. Synthesis of monorhamnosyl L-rhamno-D-mannans by conidia of Sporothrix schenckii. Infect Immun 1978; 19: 1-4.